Role of α-galactosylceramide-activated Vα14 natural killer T cells in the regulation of allergic diseases

Allergology International

Volumn 56, Issue 1, 2007, Pages 1-6

  Iwamura, Chiaki ^a   Nakayama, Toshinori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

IFN ; IgE; Th2 responses; V 14 NKT cell; Galactosylceramide

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ALLERGIC DISEASE; CELL DIFFERENTIATION; IMMUNE RESPONSE; IN VIVO STUDY; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; TH2 CELL;

EID: 33947423947     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.R-06-136     Document Type: Review

References (42)

1. Taniguchi M, Harada M, Kojo S et al. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 2003;21:483-513.
2. Godfrey DI, MacDonald HR, Kronenberg M et al. NKT cells: what's in a name? Nat. Rev. Immunol. 2004;4:231-237.
3. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 2005;23:877-900.
4. Cui J, Shin T, Kawano T et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1626.
5. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997;278:1626-1629.
6. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004;114:1379-1388.
7. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004;22:817-890.
8. Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 2003;4:1164-1165.
9. Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2001;2:293- 299.
10. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986;136:2348-2357.
11. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991;77:1859-1870.
12. Yoshimoto T, Bendelac A, Hu-Li J et al. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. U. S. A. 1995;92:11931-11934.
13. Yoshimoto T, Bendelac A, Watson C et al. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 1995;270:1845-1847.
14. Smiley ST, Kaplan MH, Grusby MJ. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997;275:977-979.
15. + T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 1996;184:1295-1304.
16. Zhang Y, Rogers KH, Lewis DB. Beta 2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 1996;184:1507-1512.
17. Guery JC, Galbiati F, Smiroldo S et al. Selective development of T helper (Th) 2 cells induced by continuous administration of low dose soluble proteins to normal and beta (2)-microglobulin-deficient BALB/c mice. J. Exp. Med. 1996;183:485-497.
18. Eberl G, Lees R, Smiley ST et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 1999;162:6410-6419.
19. + T cells in the bone marrow: divergence from the thymus. J. Immunol. 1999;163:5338-5345.
20. Hammond KJ, Pelikan SB, Crowe NY et al. NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 1999;29:3768-3781.
21. Cui J, Watanabe N, Kawano T et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J. Exp. Med. 1999;190:783-792.
22. Burdin N, Brossay L, Kronenberg M. Immunization with alpha- galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 1999;29:2014-2025.
23. Harada M, Seino K, Wakao H et al. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Int. Immunol. 2004;16:241-247.
24. Singh N, Hong S, Scherer DC et al. Cutting edge: activation of NKT cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 1999;163:2373-2377.
25. Kawano T, Cui J, Koezuka Y et al. Natural killer-like non-specific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. U. S. A. 1998;95:5690-5693.
26. Ferrick DA, Schrenzel MD, Mulvania T et al. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995;373:255-257.
27. Zuany-Amorim C, Ruffle C, Haile S et al. Requirement for gammadelta T cells in allergic airway inflammation. Science 1998;280:1265-1267.
28. Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J. Immunol. 1986;136:949-954.
29. Gajewski TF, Joyce J, Fitch FW. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J. Immunol. 1989;143:15-22.
30. McMenamin C, Pimm C, McKersey M et al. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 1994;265:1869-1871.
31. Szczepanik M, Anderson LR, Ushio H et al. Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-gamma production in vitro. J. Exp. Med. 1996;184:2129-2139.
32. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol. Today 1992;13:379-381.
33. Kitamura H, Iwakabe K, Yahata T et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 1999;189:1121-1128.
34. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 1999;163:93-101.
35. Yamashita M, Kimura M, Kubo M et al. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 1999;96:1024- 1029.
36. Matsuda H, Suda T, Sato J et al. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 2005;33:22-31.
37. Hachem P, Lisbonne M, Michel ML et al. Alpha-galactosylceramide- induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur. J. Immunol. 2005;35:2793-2802.
38. Morishima Y, Ishii Y, Kimura T et al. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur. J. Immunol. 2005;35:2803-2814.
39. Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 2003;9:582-588.
40. + NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 2006;103:2782-2787.
41. Kinjo Y, Wu D, Kim G et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005;434:520- 525.
42. Mattner J, Debord KL, Ismail N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005;434:525-529.